IS5934A - Nýir esterar leiddir af útskiptum fenýlsyklóhexýlefnasamböndum - Google Patents

Nýir esterar leiddir af útskiptum fenýlsyklóhexýlefnasamböndum

Info

Publication number
IS5934A
IS5934A IS5934A IS5934A IS5934A IS 5934 A IS5934 A IS 5934A IS 5934 A IS5934 A IS 5934A IS 5934 A IS5934 A IS 5934A IS 5934 A IS5934 A IS 5934A
Authority
IS
Iceland
Prior art keywords
substituted
new esters
esters result
phenylcyclohexyl
compounds
Prior art date
Application number
IS5934A
Other languages
English (en)
Inventor
Carlos Del Castillo Nieto Juan
Original Assignee
Laboratorios Vita, S.A.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Laboratorios Vita, S.A. filed Critical Laboratorios Vita, S.A.
Publication of IS5934A publication Critical patent/IS5934A/is

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C219/00Compounds containing amino and esterified hydroxy groups bound to the same carbon skeleton
    • C07C219/26Compounds containing amino and esterified hydroxy groups bound to the same carbon skeleton having esterified hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C271/00Derivatives of carbamic acids, i.e. compounds containing any of the groups, the nitrogen atom not being part of nitro or nitroso groups
    • C07C271/06Esters of carbamic acids
    • C07C271/40Esters of carbamic acids having oxygen atoms of carbamate groups bound to carbon atoms of six-membered aromatic rings
    • C07C271/42Esters of carbamic acids having oxygen atoms of carbamate groups bound to carbon atoms of six-membered aromatic rings with the nitrogen atoms of the carbamate groups bound to hydrogen atoms or to acyclic carbon atoms
    • C07C271/44Esters of carbamic acids having oxygen atoms of carbamate groups bound to carbon atoms of six-membered aromatic rings with the nitrogen atoms of the carbamate groups bound to hydrogen atoms or to acyclic carbon atoms to hydrogen atoms or to carbon atoms of unsubstituted hydrocarbon radicals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C219/00Compounds containing amino and esterified hydroxy groups bound to the same carbon skeleton
    • C07C219/26Compounds containing amino and esterified hydroxy groups bound to the same carbon skeleton having esterified hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton
    • C07C219/28Compounds containing amino and esterified hydroxy groups bound to the same carbon skeleton having esterified hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton having amino groups bound to acyclic carbon atoms of the carbon skeleton
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C219/00Compounds containing amino and esterified hydroxy groups bound to the same carbon skeleton
    • C07C219/26Compounds containing amino and esterified hydroxy groups bound to the same carbon skeleton having esterified hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton
    • C07C219/28Compounds containing amino and esterified hydroxy groups bound to the same carbon skeleton having esterified hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton having amino groups bound to acyclic carbon atoms of the carbon skeleton
    • C07C219/30Compounds containing amino and esterified hydroxy groups bound to the same carbon skeleton having esterified hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton having amino groups bound to acyclic carbon atoms of the carbon skeleton with amino groups linked to the six-membered aromatic ring, or to the condensed ring system containing that ring, by carbon chains further substituted by singly-bound oxygen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04Ortho-condensed systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07BGENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00Indexing scheme relating to specific properties of organic compounds
    • C07B2200/07Optical isomers
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00Systems containing only non-condensed rings
    • C07C2601/12Systems containing only non-condensed rings with a six-membered ring
    • C07C2601/14The ring being saturated
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00Systems containing only non-condensed rings
    • C07C2601/12Systems containing only non-condensed rings with a six-membered ring
    • C07C2601/16Systems containing only non-condensed rings with a six-membered ring the ring being unsaturated
IS5934A 1998-11-06 2001-05-03 Nýir esterar leiddir af útskiptum fenýlsyklóhexýlefnasamböndum IS5934A (is)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
ES009802329A ES2141688B1 (es) 1998-11-06 1998-11-06 Nuevos esteres derivados de compuestos fenil-ciclohexil sustituidos.
PCT/ES1999/000352 WO2000027799A1 (es) 1998-11-06 1999-11-04 Nuevos esteres derivados de compuestos fenil-ciclohexil sustituidos

Publications (1)

Publication Number Publication Date
IS5934A true IS5934A (is) 2001-05-03

Family

ID=8305698

Family Applications (1)

Application Number Title Priority Date Filing Date
IS5934A IS5934A (is) 1998-11-06 2001-05-03 Nýir esterar leiddir af útskiptum fenýlsyklóhexýlefnasamböndum

Country Status (39)

Country Link
US (1) US6455585B1 (is)
EP (3) EP1219594B1 (is)
JP (1) JP2002529442A (is)
KR (1) KR100453613B1 (is)
CN (1) CN1176902C (is)
AP (1) AP1222A (is)
AT (3) ATE257837T1 (is)
AU (1) AU755681B2 (is)
BG (1) BG105556A (is)
BR (1) BR9915727A (is)
CA (1) CA2349245A1 (is)
CR (1) CR6368A (is)
CU (1) CU23006A3 (is)
CZ (1) CZ20011500A3 (is)
DE (3) DE69914229T2 (is)
DK (3) DK1219594T3 (is)
EA (1) EA003742B1 (is)
EE (1) EE200100246A (is)
ES (4) ES2141688B1 (is)
GE (1) GEP20033116B (is)
HR (1) HRP20010412B1 (is)
HU (1) HUP0104218A3 (is)
ID (1) ID29017A (is)
IL (1) IL142592A0 (is)
IS (1) IS5934A (is)
MA (1) MA26765A1 (is)
MX (1) MXPA01004432A (is)
NO (1) NO20012234D0 (is)
NZ (1) NZ511739A (is)
OA (1) OA11672A (is)
PL (1) PL347492A1 (is)
PT (3) PT1127871E (is)
SI (3) SI1127871T1 (is)
SK (1) SK284068B6 (is)
TR (3) TR200200416T2 (is)
UA (1) UA59477C2 (is)
WO (1) WO2000027799A1 (is)
YU (1) YU29601A (is)
ZA (1) ZA200104026B (is)

Families Citing this family (39)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2160534B1 (es) * 1999-12-30 2002-04-16 Vita Invest Sa Nuevos esteres derivados de (rr,ss)-2-hidroxibenzoato de 3-(2-dimetilaminometil-1-hidroxiciclohexil) fenilo.
DE10049483A1 (de) * 2000-09-29 2002-05-02 Gruenenthal Gmbh Substituierte 1-Aminobutan-3-ol-Derivate
US7776314B2 (en) 2002-06-17 2010-08-17 Grunenthal Gmbh Abuse-proofed dosage system
AU2003264311A1 (en) * 2002-08-28 2004-04-08 Jin Wang Oral formulations of ibuprofen and tramadol, methods and preparation thereof
EP3662904A1 (de) 2002-11-22 2020-06-10 Grünenthal GmbH (1r,2r)-3-(3-dimethylamino-1-ethyl-2-methyl-propyl)-phenol zur behandlung von entzündungsschmerz
US20040248979A1 (en) * 2003-06-03 2004-12-09 Dynogen Pharmaceuticals, Inc. Method of treating lower urinary tract disorders
DE102005005446A1 (de) 2005-02-04 2006-08-10 Grünenthal GmbH Bruchfeste Darreichungsformen mit retardierter Freisetzung
US8075872B2 (en) 2003-08-06 2011-12-13 Gruenenthal Gmbh Abuse-proofed dosage form
DE102004032051A1 (de) 2004-07-01 2006-01-19 Grünenthal GmbH Verfahren zur Herstellung einer gegen Missbrauch gesicherten, festen Darreichungsform
DE10336400A1 (de) 2003-08-06 2005-03-24 Grünenthal GmbH Gegen Missbrauch gesicherte Darreichungsform
US20070048228A1 (en) 2003-08-06 2007-03-01 Elisabeth Arkenau-Maric Abuse-proofed dosage form
DE10361596A1 (de) 2003-12-24 2005-09-29 Grünenthal GmbH Verfahren zur Herstellung einer gegen Missbrauch gesicherten Darreichungsform
DE102004032049A1 (de) 2004-07-01 2006-01-19 Grünenthal GmbH Gegen Missbrauch gesicherte, orale Darreichungsform
DE102004034619A1 (de) * 2004-07-16 2006-02-23 Grünenthal GmbH Substituierte Aminoverbindungen als 5-HT/NA Uptakehemmer
DE102005005449A1 (de) 2005-02-04 2006-08-10 Grünenthal GmbH Verfahren zur Herstellung einer gegen Missbrauch gesicherten Darreichungsform
DE102007011485A1 (de) 2007-03-07 2008-09-11 Grünenthal GmbH Darreichungsform mit erschwertem Missbrauch
TWI454288B (zh) 2008-01-25 2014-10-01 Gruenenthal Chemie 藥物劑型
CA2723438C (en) 2008-05-09 2016-10-11 Gruenenthal Gmbh Process for the preparation of an intermediate powder formulation and a final solid dosage form under usage of a spray congealing step
ES2534908T3 (es) 2009-07-22 2015-04-30 Grünenthal GmbH Forma de dosificación de liberación controlada extruida por fusión en caliente
BR112012001244A2 (pt) 2009-07-22 2020-12-08 Gruünenthal Gmbh Forma de dosagem resitente à adulteração, seu processo de produção, e embalagem contendo tal forma
EP2383255A1 (en) * 2010-04-28 2011-11-02 Lacer, S.A. New compounds, synthesis and use thereof in the treatment of pain
JP5925779B2 (ja) 2010-09-02 2016-05-25 グリュネンタール・ゲゼルシャフト・ミト・ベシュレンクテル・ハフツング 無機塩を含む不正使用抵抗性剤形
MX2013002293A (es) 2010-09-02 2013-05-09 Gruenenthal Gmbh Forma de dosificacion resistente a alteracion que comprende un polimero anionico.
WO2012100423A1 (en) * 2011-01-27 2012-08-02 Eli Lilly And Company Analgesic compounds, methods, and formulations
EP2530072A1 (en) 2011-06-03 2012-12-05 Lacer, S.A. New compounds, synthesis and use thereof in the treatment of pain
US10702485B2 (en) 2011-07-09 2020-07-07 Syntrix Biosystems Inc. Compositions and methods for overcoming resistance to tramadol
JP6063462B2 (ja) 2011-07-29 2017-01-18 グリュネンタール・ゲゼルシャフト・ミト・ベシュレンクテル・ハフツング 即時薬剤放出を提供するタンパーレジスタント錠剤
JP2014524925A (ja) 2011-07-29 2014-09-25 グリュネンタール・ゲゼルシャフト・ミト・ベシュレンクテル・ハフツング 即時薬剤放出を提供するタンパーレジスタント錠剤
MX356421B (es) 2012-02-28 2018-05-29 Gruenenthal Gmbh Forma de dosificacion resistente a la manipulacion indebida que comprende un compuesto farmacologicamente activo y un polimero anionico.
MX362357B (es) 2012-04-18 2019-01-14 Gruenenthal Gmbh Forma de dosificacion farmaceutica resistente a la adulteracion y resistente a la liberacion inmediata de la dosis.
WO2013168005A2 (en) * 2012-05-10 2013-11-14 Mahesh Kandula Compositions and methods for the treatment of restless leg syndrome and fibromyalgia
US10064945B2 (en) 2012-05-11 2018-09-04 Gruenenthal Gmbh Thermoformed, tamper-resistant pharmaceutical dosage form containing zinc
MX2015016254A (es) 2013-05-29 2016-04-20 Gruenenthal Gmbh Forma de dosificacion resistente al uso indebido con perfil de liberacion bimodal.
BR112015026549A2 (pt) 2013-05-29 2017-07-25 Gruenenthal Gmbh forma de dosagem à prova de violação contendo uma ou mais partículas
CN105682643B (zh) 2013-07-12 2019-12-13 格吕伦塔尔有限公司 含有乙烯-醋酸乙烯酯聚合物的防篡改剂型
CA2931553C (en) 2013-11-26 2022-01-18 Grunenthal Gmbh Preparation of a powdery pharmaceutical composition by means of cryo-milling
CA2947786A1 (en) 2014-05-12 2015-11-19 Grunenthal Gmbh Tamper resistant immediate release capsule formulation comprising tapentadol
CA2983642A1 (en) 2015-04-24 2016-10-27 Grunenthal Gmbh Tamper-resistant dosage form with immediate release and resistance against solvent extraction
EP3346991A1 (en) 2015-09-10 2018-07-18 Grünenthal GmbH Protecting oral overdose with abuse deterrent immediate release formulations

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1199764B (de) * 1963-04-02 1965-09-02 Gruenenthal Chemie Verfahren zur Herstellung von basisch substituierten Phenolaethern
US3652589A (en) * 1967-07-27 1972-03-28 Gruenenthal Chemie 1-(m-substituted phenyl)-2-aminomethyl cyclohexanols
DE19525137C2 (de) * 1995-07-11 2003-02-27 Gruenenthal Gmbh 6-Dimethylaminomethyl-1-phenyl-cyclohexanverbin -dungen als Zwischenprodukte zur Herstellung pharmazeutischer Wirkstoffe
DE19609847A1 (de) * 1996-03-13 1997-09-18 Gruenenthal Gmbh Dimethyl-(3-aryl-but-3-enyl)-aminverbindungen als pharmazeutische Wirkstoffe

Also Published As

Publication number Publication date
ES2141688A1 (es) 2000-05-16
TR200200415T2 (tr) 2002-06-21
CU23006A3 (es) 2004-12-17
KR20010080942A (ko) 2001-08-25
ES2141688B1 (es) 2001-02-01
ID29017A (id) 2001-07-26
ATE257837T1 (de) 2004-01-15
CR6368A (es) 2002-04-08
ATE249418T1 (de) 2003-09-15
CN1325377A (zh) 2001-12-05
AU1047300A (en) 2000-05-29
YU29601A (sh) 2003-04-30
EP1127871A1 (en) 2001-08-29
MXPA01004432A (es) 2002-09-18
KR100453613B1 (ko) 2004-10-20
AP1222A (en) 2003-11-06
HUP0104218A2 (hu) 2002-03-28
HUP0104218A3 (en) 2002-11-28
ATE257817T1 (de) 2004-01-15
CZ20011500A3 (cs) 2001-09-12
EA200100476A1 (ru) 2002-02-28
SK284068B6 (sk) 2004-09-08
EP1219594A1 (en) 2002-07-03
ZA200104026B (en) 2002-05-17
MA26765A1 (fr) 2004-12-20
PT1127871E (pt) 2003-12-31
PT1219623E (pt) 2004-04-30
ES2213732T3 (es) 2004-09-01
SI1219594T1 (en) 2004-06-30
DE69911235T2 (de) 2004-07-01
DE69914231D1 (de) 2004-02-19
SI1219623T1 (en) 2004-06-30
TR200101160T2 (tr) 2002-01-21
EP1219623B1 (en) 2004-01-14
PL347492A1 (en) 2002-04-08
SI1127871T1 (en) 2004-02-29
SK5842001A3 (en) 2001-12-03
AU755681B2 (en) 2002-12-19
HRP20010412A2 (en) 2002-12-31
EA003742B1 (ru) 2003-08-28
DE69914229D1 (de) 2004-02-19
NZ511739A (en) 2002-11-26
UA59477C2 (uk) 2003-09-15
DE69914231T2 (de) 2004-11-11
NO20012234L (no) 2001-05-04
CN1176902C (zh) 2004-11-24
NO20012234D0 (no) 2001-05-04
WO2000027799A1 (es) 2000-05-18
CA2349245A1 (en) 2000-05-18
DK1219594T3 (da) 2004-04-19
DK1219623T3 (da) 2004-04-19
EE200100246A (et) 2002-12-16
HRP20010412B1 (en) 2004-04-30
DE69911235D1 (de) 2003-10-16
OA11672A (en) 2005-01-12
EP1127871B1 (en) 2003-09-10
GEP20033116B (en) 2003-11-25
BG105556A (en) 2001-12-29
ES2213731T3 (es) 2004-09-01
JP2002529442A (ja) 2002-09-10
BR9915727A (pt) 2001-09-04
US6455585B1 (en) 2002-09-24
EP1219594B1 (en) 2004-01-14
PT1219594E (pt) 2004-04-30
EP1219623A1 (en) 2002-07-03
IL142592A0 (en) 2002-03-10
DE69914229T2 (de) 2004-12-09
DK1127871T3 (da) 2003-11-24
TR200200416T2 (tr) 2003-01-21
ES2207298T3 (es) 2004-05-16

Similar Documents

Publication Publication Date Title
IS5934A (is) Nýir esterar leiddir af útskiptum fenýlsyklóhexýlefnasamböndum
FIU990190U0 (fi) Uusia yhdisteitä
DK1772141T3 (da) Fremgangsmåde til gennemföring af krystallisation i fast tilstand
LTPA2009006I1 (lt) Trombopoetino junginiai
ID28266A (id) Senyawa-senyawa amidin
NO20011745L (no) Forbindelser
DK1107980T3 (da) Krystallinske former af EtO2C-CH2-(R)Cgl-Aze-Pab-OH
NO20005006D0 (no) Kalsilytiske forbindelser
NO20006662L (no) Fluorfenylresin-forbindelser
DK0745011T3 (da) Dannelse af gevind
IS5821A (is) Kristalluð form af ósanetant
ID22727A (id) Senyawa ester
SE9800511D0 (sv) New compounds
SE9800512D0 (sv) New compounds
SE9800509D0 (sv) New Compounds
SE9800977D0 (sv) New compounds
SE9803747D0 (sv) New compounds
SE9803746D0 (sv) New compounds
SE9800510D0 (sv) New Compounds
SE9801099D0 (sv) New compounds
SE9800508D0 (sv) New Compounds
SE9800834D0 (sv) New Compounds
IDP000021790A (id) Senyawa-senyawa pirolum tersubstitusi
IDP000021799A (id) Senyawa-senyawa pirolum tersubstitusi
SE9801989D0 (sv) Novel compounds